Dear All, I have learned that the Ineos Oxford Institute for Antimicrobial Research (IOI) has started a job search for a Director for the IOI. As background, IOI was created in 2021 with a £100m donation from INEOS, one of the world’s largest manufacturing companies (Wikipedia; INEOS corporate website). Per their research webpage, IOI is
24 Mar 2025 update: The call is live! It’s entitled “Development of a Rapid Point-of-care Antimicrobial Susceptibility Testing Diagnostic Medical Device (HADEA/2025/CPN/0006).” To apply, you must submit a request to participate by 12 May 2025; selected candidates who met the eligibility criteria will be able to submit a full technical tender. See the 24 Mar 2025 newsletter for a
Dear All, EMA have recently posted a call for tenders under which they seek to “procure the services of research organizations to perform studies on the quality, safety and efficacy of human and veterinary medicines that would provide complementary evidence to support regulatory decision-making.” It’s not specifically about AMR (or, indeed, about any particular therapy
Dear All, The Advisory Committee on Immunization Practices (ACIP) is scheduled to meet 26-28 Feb 2025 (see links below my signature for deeper background on ACIP and how it advises on vaccine use). At least as of today, the ACIP meeting is scheduled to occur as planned: it has a full agenda that covers meningococcal vaccine, influenza
Dear All, If you are attending ESCMID Global in Vienna this year, mark your calendar for two major events. I hope to see you at both of them! First, there will be a Science Policy Forum afternoon (with networking reception) on Friday, 11 April 2025. Refined over the past two iterations of ECCMID, this event was
Dear All, A huge announcement today backed by the combined power of the Gates Foundation, Novo Nordisk, and Wellcome! I am going to quote liberally from their materials: Responding to the problem of AMR, “… the Novo Nordisk Foundation (NNF), Wellcome, and the Gates Foundation (GF) are jointly launching a new initiative, Gram-Negative Antibiotic Discovery
Dear All, Sadly, I must report that the 27th meeting of PACCARB (the US Presidential Advisory Council on Combatting Antibiotic-Resistant Bacteria) planned for 28-29 Jan 2025 has been cancelled “as the new Administration considers its plan for managing federal policy and public communications.” This 22 Jan 2025 article in the New York Times provides additional details
Dear All, Three things for today along with some great acronyms! To start, we have an announcement of the first ever National One Health Framework to Address Zoonotic Diseases and Advance Public Health Preparedness in the United States (NOHF-Zoonoses) (website, .pdf of the framework). As a reminder, a zoonosis is an infection that jumps from
Dear All (and with thanks to Damiano for taking the lead on this newsletter), We start the new year with good news from Rome! On Saturday 28 December 2024, the Italian Senate passed the government’s 2025 budget, giving parliament’s final approval to a financial package which includes a pull incentive for innovative antibiotics. As promised by Minister
Dear All, I wrote in the 1 Dec 2024 newsletter about the excellent paper by Baraldi et al. that introduced us to the 6 possible meaning of “lack of access.” Since that newsletter, a bit of back-and-forth has produced a UNSLAP as a pronounceable acronym for the 6 meanings: (U)nregistered, (N)ever registered (or, not registered),